Single-cell technologies are part of broad genomics and proteomics. These technologies are being used to understand the diverse application of biology and disease, such as development, microbial population composition, and cancer evolution.
MARKET DYNAMICS
The single-cell omics market growth is anticipated to grow due to increasing applications of single-cell omics, new product and technology launches, and increasing applications of genomics and proteomics. The market is expected to have growth opportunities due to rising awareness about single-cell omics and its applications and the growing adoption of omics in the developing regions.
MARKET SCOPE
The "Single cell omics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of single cell omics market with detailed market segmentation by technology, application, and end user. The single cell omics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in single cell omics market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The single cell omics market is segmented on the basis of, technology, application, and end user. Based on technology, the market is classified as tubing PCR, qPCR, microarray, next generation sequencing, and others. Based on application, the market is divided into genomic variation, subpopulation characterization, circulating tumor cells, cell differentiation, and others. Based on end user, the market is classified as academic institutes, biopharmaceutical companies, and clinical research institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the single cell omics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The single cell omics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting single cell omics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the single cell omics market in these regions.
MARKET PLAYERS
The report covers key developments in the single cell omics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from single cell omics market are anticipated to have lucrative growth opportunities in the future with the rising demand for single cell omics in the global market. Below mentioned is the list of few companies engaged in the single cell omics market.
The report also includes the profiles of key players in single cell omics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific Inc.
- Qiagen N.V.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- 10x Genomics, Inc.
- Namocell Inc.
- Takara Bio, Inc.
- Cytiva (GE Healthcare Life Sciences)
- Agilent Technologies Inc.
- NanoString Technologies, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.